Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00695357
NCT00695357
Completed
Not Applicable

Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006

AstraZeneca1 site in 1 country832 target enrollmentApril 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNew StrategiesGINA 2006Patient Opinion

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
New Strategies
Sponsor
AstraZeneca
Enrollment
832
Locations
1
Primary Endpoint
Percentage (%) of Asthma treatment satisfaction and control grading
Status
Completed
Last Updated
17 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

Cross-sectional, one visit study. All the data will be collected through questionnaires. Descriptives statistics will be applied to the data. 832 patients will participate to the study and 104 physicians.

Registry
clinicaltrials.gov
Start Date
April 2008
End Date
June 2008
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients diagnosed with persistent asthma (GINA 2005) for at least 6 months before entering the study
  • •Patients who are under treatment according to the new strategies described in GINA 2006 for at least 3 months before entering the study

Exclusion Criteria

  • •Patients who are not willing to sign the Informed Consent Form
  • •COPD Patients

Outcomes

Primary Outcomes

Percentage (%) of Asthma treatment satisfaction and control grading

Time Frame: single visit / once

Secondary Outcomes

  • Rate of treatment compliance(single visit / once)
  • Patients quality of life under treatment(single visit / once)

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
A Hospital Based Survey on Lung Cancer Related-pain in Northern ChinaCancer PainLung Cancer
NCT03189277Chinese Academy of Medical Sciences2,000
Completed
Not Applicable
A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Access to Medicines Scheme (EAMS) Program in the United KingdomEsophageal Squamous Cell Carcinoma
NCT04936399Bristol-Myers Squibb87
Completed
Not Applicable
Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in GreeceChronic Obstructive Pulmonary Disease
NCT02187926AstraZeneca2,577
Completed
Not Applicable
Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant TherapyDisseminated HER2+ Breast Cancer
NCT01645059Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica129
Completed
Not Applicable
Subjective Well Being of Patients Receiving Atypical Antipsychotics as Monotherapy or Cotherapy With Mood StabilizersBipolar Disorder
NCT00691353AstraZeneca540